Table 1 Baseline Demographics Mean (SD) or %
| Â | Atorvastatin | Combination |
|---|---|---|
Age (years) | 67.09 (9.668) | 60.50 (9.561) |
Male Sex | 85 | 73.9 |
Coronary artery disease (%) | 60 | 43.5 |
   Angina | 40 | 39.1 |
   Previous Myocardial Infarction | 35 | 13 |
   Previous PCI | 40 | 21.7 |
   Previous CABG | 15 | 21.7 |
Cerebrovascular Disease (%) | 45 | 60.9 |
Peripheral Vascular Disease (%) | 0 | 4.3 |
Lipid Parameters | Â | Â |
   Total Cholesterol (mmol/L) | 5.69 (0.78) | 5.98 (0.91) |
   Low density lipoprotein (mmol/L) | 3.58 (0.53) | 3.91 (0.71) |
   High density lipoprotein (mmol/L) | 1.31 (0.28) | 1.44 (0.20) |
   Triglycerides (mmol/L) | 1.75 (0.70) | 1.35 (0.49) |
   TC/HDL Ratio | 4.49 (0.97) | 4.20 (0.65) |
Smoking Status (%) | Â | Â |
   Never Smoked | 25 | 34.8 |
   Previous Smoker | 70 | 52.2 |
   Current Smoker | 5 | 13 |
Diabetes Mellitus (%) | 10 | 30.4 |
Body Mass Index (kg/m2) | 27.8 (3.50) | 28.2 (5.43) |
Weight (kg) | 83.2 (12.80) | 82.2 (17.82) |
History of Hypertension (%) | 60 | 65.2 |
Systolic Blood Pressure (mmHg) | 128.4 (16.14) | 121.4 (15.88) |
Diastolic Blood Pressure (mmHg) | 73.2 (8.57) | 72.9 (11.68) |
Mean hsCRP | 3.62 (3.59) | 2.91 (4.18) |
Antithrombotic Therapy # (%) | 19 (95) | 23 (100) |
Previous Lipid-Lowering Therapy # (%) | 12 (60) | 15 (65.2) |
ACE-I/ATII Therapy # (%) | 15 (75.0) | 20 (87.0) |